Filing Flows › Nexgel (NXGL) › Q2 2025
Nexgel (NXGL) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 12, 2025
Nexgel (NXGL) reported revenue of $2.9M for the second quarter 2025 (Q2 2025), +100% from a year earlier and +3% from the quarter before. Operating margin was -22.1%, net loss $640K (22.2% of revenue).
Nexgel, Q2 2025: revenue $2.9M (+100% year over year), operating margin -22.1%, net loss $640K, operating cash flow −$407K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.9M | +3% | +100% |
| Operating profit | −$636K | — | — |
| Net earnings | −$640K | — | — |
| Operating cash flow | −$407K | — | — |
What changed
Revenue was $2.9M in Q2 2025, up 100% year over year and up 3% from the previous quarter.
Gross margin was 43.6%, up 23.3 points from a year earlier. Operating costs exceeded revenue by $636K, an operating margin of -22.1%. Operating expenses grew 41% against revenue growth of 100%. The quarter ended with a net loss of $640K, narrower than the previous quarter's $678K loss.
Operating cash flow was −$407K. Non-cash charges added back $111K of depreciation and amortization and $127K of share-based compensation.
Questions
What was Nexgel's revenue in the second quarter 2025?
Nexgel (NXGL) reported revenue of $2.9M for the second quarter 2025 (Q2 2025), +100% from a year earlier and +3% from the quarter before.
Was Nexgel profitable in the second quarter 2025?
Operating loss was $636K (-22.1% of revenue) and net loss $640K.
Source: Nexgel 10-Q on SEC EDGAR.